These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 9443094)
1. Management of ductal carcinoma in situ of the breast--experiences from National Naval Medical Center during last 10 years. Park ST; Hamilton M; Ghosh BC J Korean Med Sci; 1997 Dec; 12(6):545-9. PubMed ID: 9443094 [TBL] [Abstract][Full Text] [Related]
2. Incidence of and treatment for ductal carcinoma in situ of the breast. Ernster VL; Barclay J; Kerlikowske K; Grady D; Henderson C JAMA; 1996 Mar; 275(12):913-8. PubMed ID: 8598618 [TBL] [Abstract][Full Text] [Related]
3. Outcome and prognostic factors for local recurrence in mammographically detected ductal carcinoma in situ of the breast treated with conservative surgery and radiation therapy. White J; Levine A; Gustafson G; Wimbish K; Ingold J; Pettinga J; Matter R; Martinez A; Vicini F Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):791-7. PubMed ID: 7860390 [TBL] [Abstract][Full Text] [Related]
4. Ductal carcinoma in situ. The success of breast conservation therapy: a shared experience of two single institutional nonrandomized prospective studies. Lagios MD; Silverstein MJ Surg Oncol Clin N Am; 1997 Apr; 6(2):385-92. PubMed ID: 9115503 [TBL] [Abstract][Full Text] [Related]
5. Ductal carcinoma in situ of the breast in Israeli women treated by breast-conserving surgery followed by radiation therapy. Jiveliouk I; Corn B; Inbar M; Merimsky O Oncology; 2009; 76(1):30-5. PubMed ID: 19033713 [TBL] [Abstract][Full Text] [Related]
6. Cytologic evaluation of lumpectomy margins in patients with ductal carcinoma in situ: clinical outcome. Cox CE; Hyacinthe M; Gonzalez RJ; Lyman G; Reintgen D; Ku NN; Miller MS; Greenberg H; Nicosia SV Ann Surg Oncol; 1997 Dec; 4(8):644-9. PubMed ID: 9416412 [TBL] [Abstract][Full Text] [Related]
7. Management of ductal carcinoma in situ of the breast. Carty NJ; Carter C; Royle GT; Johnson CD Ann R Coll Surg Engl; 1995 May; 77(3):163-7. PubMed ID: 7598411 [TBL] [Abstract][Full Text] [Related]
8. Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience. Padmore RF; Fowble B; Hoffman J; Rosser C; Hanlon A; Patchefsky AS Cancer; 2000 Mar; 88(6):1403-9. PubMed ID: 10717623 [TBL] [Abstract][Full Text] [Related]
9. Influence of local treatment on the recurrence rate of ductal carcinoma in situ. Warneke J; Grossklaus D; Davis J; Stea B; Bebb G; Taylor C; Hastings R; Villar H J Am Coll Surg; 1995 Jun; 180(6):683-8. PubMed ID: 7773481 [TBL] [Abstract][Full Text] [Related]
10. Long-term outcome after postmastectomy radiation therapy for the treatment of ductal carcinoma in situ of the breast. Metz JM; Solin LJ Am J Clin Oncol; 1999 Jun; 22(3):215-7. PubMed ID: 10362324 [TBL] [Abstract][Full Text] [Related]
11. [Intraductal carcinoma of the breast (DCIS). Should the treatment be conservative or not?]. Barreau-Pouhaer L; Petit JY; Fontaine F; Contesso G Ann Chir; 1993; 47(5):386-91; discussion 391-3. PubMed ID: 8215161 [TBL] [Abstract][Full Text] [Related]
12. Lumpectomy with and without radiation for early-stage breast cancer and DCIS. Marks LB; Prosnitz LR Oncology (Williston Park); 1997 Sep; 11(9):1361-8, 1371; discussion 1372, 1374. PubMed ID: 9306425 [TBL] [Abstract][Full Text] [Related]
13. Ductal carcinoma in situ treated with breast-conserving surgery and radiotherapy: a comparison with ECOG study 5194. Motwani SB; Goyal S; Moran MS; Chhabra A; Haffty BG Cancer; 2011 Mar; 117(6):1156-62. PubMed ID: 21381008 [TBL] [Abstract][Full Text] [Related]
14. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. Tuttle TM; Jarosek S; Habermann EB; Arrington A; Abraham A; Morris TJ; Virnig BA J Clin Oncol; 2009 Mar; 27(9):1362-7. PubMed ID: 19224844 [TBL] [Abstract][Full Text] [Related]
15. [Breast reconstruction after skin-sparing mastectomy or nipple-sparing mastectomy for breast cancer]. Chen J; Lü Q; Wang X; Li H; Chen Y; Yang X; Zeng H Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jul; 27(7):872-5. PubMed ID: 24063181 [TBL] [Abstract][Full Text] [Related]
16. Does the volume of ductal carcinoma in situ impact the positive margin rate in patients undergoing breast conservation for invasive breast cancer? Martin-Dunlap TM; Cyr AE; Al Mushawah F; Gao F; Margenthaler JA J Surg Res; 2013 Sep; 184(1):228-33. PubMed ID: 23688789 [TBL] [Abstract][Full Text] [Related]
17. Incidence of occult contralateral carcinomas of the breast following mastoplasty aimed at symmetrization. Sorin T; Fyad JP; Pujo J; Colson T; Bordes V; Leroux A; Marchal F; Brix M; Simon E; Verhaeghe JL; Classe JM; Dolivet G Ann Chir Plast Esthet; 2014 Apr; 59(2):e21-8. PubMed ID: 24530086 [TBL] [Abstract][Full Text] [Related]
18. Is radiation indicated in patients with ductal carcinoma in situ and close or positive mastectomy margins? Chan LW; Rabban J; Hwang ES; Bevan A; Alvarado M; Ewing C; Esserman L; Fowble B Int J Radiat Oncol Biol Phys; 2011 May; 80(1):25-30. PubMed ID: 20646871 [TBL] [Abstract][Full Text] [Related]
19. Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Silverstein MJ; Barth A; Poller DN; Gierson ED; Colburn WJ; Waisman JR; Gamagami P Eur J Cancer; 1995; 31A(9):1425-7. PubMed ID: 7577065 [TBL] [Abstract][Full Text] [Related]
20. Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy. Tunon-de-Lara C; Giard S; Buttarelli M; Blanchot J; Classe JM; Baron M; Monnier B; Houvenaeghel G Breast J; 2008; 14(2):135-40. PubMed ID: 18315691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]